Benzinga's Microcap Movers for Thursday October 4, 2012
Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:
Shares of LodgeNet (NASDAQ: LNET), the Sioux Falls, SD provider of provider of interactive media and connectivity services to the hospitality and healthcare industries, rose 16.54% Thursday on 5 times average volume.
LodgeNet announced Wednesday they were certified by Marriott International as a Marriott Global Property Network Standards approved provider for property Internet.
LodgeNet closed at $0.74 on Thursday.
Shares of Escalon Medical (NASDAQ: ESMC), the Wayne, PA medical device company, rose 151% Thursday on 31 times average volume.
Escalon announced Thursday the sale of its Clinical Diagnostics Business to ERBA Diagnostics (NYSE: ERB) for $6.5 million in cash.
Escalon Medical closed at $0.98 on Thursday.
Neuralstem (NYSE: CUR), the Rockville, MD stem cell company, rose 12.28% Thursday on 3.75 times average volume.
Neuralstem announced Thursday it will provide an update of the Phase I trial to test Neuralstem's human spinal cord stem cells, NSI-566, in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at the American Neurological Association annual meeting on Monday, October 8th.
Neuralstem closed at $1.28 on Thursday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.